Kutschenko, Anna
Klietz, Martin
Paracka, Lejla
Kollewe, Katja
Schulte-Sutum, Annika
Janssen, Theda
Schrader, Christoph
Wegner, Florian
Dressler, Dirk
Article History
Received: 4 May 2020
Accepted: 17 June 2020
First Online: 25 June 2020
Compliance with ethical standards
:
: DD received honoraria for services provided to Allergan, Ipsen, Merz, Lanzhou Institute of Biological Products, Medy-Tox, Revance, Desitin, Syntaxin, Abbvie, Medtronic, St Jude, Boston Scientific, Almirall, Bayer, Sun, Teva, UCB, IAB-Interdisciplinary Working Group for Movement Disorders. He is shareholder of Allergan and holds patents on botulinum toxin and botulinum toxin therapy. He provides professional consulting services to pharmaceutical companies and professional investment institutions on all aspects of botulinum toxin drugs. MK received honoraria for services provided to Novartis and has received research support for the German “Arbeitskreis Botulinumtoxin”. KK received travel grants and/or honoraria for lectures from Allergan, Biogen, Ipsen, Lilly, Merz, Novartis, Teva. AK, LP, ASS, TJ, FW have no conflict of interest to report.
: The study was approved by the local Ethics Committee of Hannover Medical School. All the procedures being performed were part of the routine care.
: Patients gave written informed consent to the restrospective analysis of their digital BT therapy data.
: Patients gave written informed consent for the publication.